Abstract

Lipid A is an essential basal component of lipopolysaccharide of most Gram-negative bacteria. Inhibitors targeting LpxC, a conserved enzyme in lipid A biosynthesis, are antibiotic candidates against Gram-negative pathogens. Here we report the characterization of the role of lipid A in Coxiella burnetii growth in axenic media, monkey kidney cells (BGMK and Vero), and macrophage-like THP-1 cells by using a potent LpxC inhibitor -LPC-011. We first determined the susceptibility of C. burnetii LpxC to LPC-011 in a surrogate E. coli model. In E. coli, the minimum inhibitory concentration (MIC) of LPC-011 against C. burnetii LpxC is < 0.05 μg/mL, a value lower than the inhibitor's MIC against E. coli LpxC. Considering the inhibitor's problematic pharmacokinetic properties in vivo and Coxiella's culturing time up to 7 days, the stability of LPC-011 in cell cultures was assessed. We found that regularly changing inhibitor-containing media was required for sustained inhibition of C. burnetii LpxC in cells. Under inhibitor treatment, Coxiella has reduced growth yields in axenic media and during replication in non-phagocytic cells, and has a reduced number of productive vacuoles in such cells. Inhibiting lipid A biosynthesis in C. burnetii by the inhibitor was shown in a phase II strain transformed with chlamydial kdtA. This exogenous KdtA enzyme modifies Coxiella lipid A with an α-Kdo-(2 → 8)-α-Kdo epitope that can be detected by anti-chlamydia genus antibodies. In inhibitor-treated THP-1 cells, Coxiella shows severe growth defects characterized by poor vacuole formation and low growth yields. Coxiella progenies prepared from inhibitor-treated cells retain the capability of normally infecting all tested cells in the absence of the inhibitor, which suggests a dispensable role of lipid A for infection and early vacuole development. In conclusion, our data suggest that lipid A has significance for optimal development of Coxiella-containing vacuoles, and for robust multiplication of C. burnetii in macrophage-like THP-1 cells. Unlike many bacteria, C. burnetii replication in axenic media and non-phagocytic cells was less dependent on normal lipid A biosynthesis.

Highlights

  • Coxiella burnetii is a geographically widely distributed, Gramnegative intracellular bacterium

  • Because lipid A is essential for the viability of most Gram-negative bacteria, we tested the effectiveness of a broad-spectrum LpxC inhibitor –LPC-011 as a potential anti-Coxiella agent

  • No perceptible phenotypes were observed during cell cultures of C. burnetii, similar cell toxicity was observed at high concentrations of LPC-011 (Nguyen et al, 2011), suggesting lipid A could be dispensable for C. burnetii culture in Vero cells

Read more

Summary

Introduction

Coxiella burnetii is a geographically widely distributed, Gramnegative intracellular bacterium. It is the causative agent of Q fever which may manifest in humans as an acute disease (mainly as a self-limiting febrile illness, pneumonia, or hepatitis) or as a chronic disease (mainly endocarditis in patients with previous valvulopathy) (Maurin and Raoult, 1999). The majority (∼50–60%) of human infections are asymptomatic (Maurin and Raoult, 1999; Hechemy, 2012). Chronic infections are rare but can be fatal if untreated. Treatment of chronic infections is challenging and currently requires a combined antibiotic therapy with doxycycline and hydroxychloroquine for a minimum of 18 months (Angelakis and Raoult, 2010)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call